| Microbioma, AlimentaciΓ³n y Salud (BEA) |
M. Victoria Moreno Arribas |
Madrid |
CIAL |
|
|
|
Human |
Ulcerative Colitis patiens, Healthy individuals (adults) and nutritional interventions, Metabolic syndrome-Cardiovascular disease patients, SARS-CoV-2 patients, Nursing homes residents, Early Alzheimer patients, Infant metagenomes and food contaminants |
Ulcerative Colitis patients-Oral and Intestinal microbiome (CIAL-CSIC, BEA group), Oral microbiome and polyphenols intervention (CIAL-CSIC, BEA group), Polyphenols supplementation effects on human gut microbiome (CIAL-CSIC, BEA group), Inter-individual variability in intestinal polyphenols metabolism (CIAL-CSIC, BEA group), Microbiome-aging, nursing homes, metagenomics, resistome (CIAL-CSIC, BEA group), Intestinal microbiota role in cardiometabolic disorders (CIAL-CSIC, BEA group), Ulcerative Colitis patients - Polyphenols and oral and Intestinal microbiome (CIAL-CSIC, BEA group), Intestinal microbiome SARS-CoV-2 patients, included recurrent PCR+ (CIAL-CSIC, BEA group), Microbial metabolism and intestinal barrier, Alzheimer patients - Microbiome (CIAL-CSIC, BEA Group) |
| MicroHealth |
Susana Delgado Palacio |
Asturias |
IPLA |
|
|
|
Human |
Probiotabank |
Lactic acid bacteria (IPLA), Bifidobacteria (IPLA), Streptococcus (IPLA), Healthy children metataxonomies (IPLA), Blautia (IPLA), Clostridia (IPLA), Isolates from the human gastrointestinal tract (IPLA) |
| MicroHealth |
Patricia Ruas Madiedo |
Asturias |
IPLA |
|
|
|
Human, Food |
|
Food metagenomes (IPLA), Bacteria from whey (rennet coagulated milk in the lab) (IPLA), Bacteria from Gamoneu cheese rind (IPLA), Isolates from the human gastrointestinal tract (IPLA) |
| MicroHealth |
Abelardo Margolles Barros |
Asturias |
IPLA |
|
|
|
Human |
|
Human adult metagenomes (IPLA), Isolates from the human gastrointestinal tract (IPLA) |
| MicroHealth |
Lorena Ruiz GarcΓa |
Asturias |
IPLA |
|
|
|
Human, Food |
|
Bacteria from beer bagasse (BSG) (IPLA), Bacteria from artichoke (IPLA), Yeast from beer bagasse (BSG) (IPLA), Yeast from artichoke (IPLA), Bacteria from apple pomace (IPLA), Yeast from apple pomace (IPLA), Isolates from the human gastrointestinal tract (IPLA) |
| Microbial Ecology, Nutrition and Health |
Alfonso BenΓtez-PΓ‘ez |
Comunitat Valenciana |
IATA-CSIC |
Human gut microbiome research; diet and host-microbiota interactions; clinical and intervention microbiome studies (amplicon, shotgun metagenomics, rrn operon long-read sequencing) |
16S rRNA V3-V4 amplicon sequencing (Illumina); full-length rrn operon (16S-ITS-23S) amplicon sequencing (Oxford Nanopore MinION); shotgun metagenomics (Illumina) |
|
Human, Animal |
|
rrn operon ONT sequencing from human feces - CeD patients and relatives (IATA), rrn operon ONT sequencing from human feces - COVID patients (IATA), rrn operon ONT sequencing from human feces - FMT (IATA), V3-V4 16S amplicons from human feces - AXOS intervention (IATA), V3-V4 16S amplicons from human feces - UCI patients (IATA), V3-V4 16S amplicons from human feces - newborns with CeD (IATA), V3-V4 16S amplicons from human feces - obese+IR children (IATA), V3-V4 16S amplicons from human feces - Wilson Disease (IATA), V3-V4 16S amplicons from rats - extracellular vesicles intervention (IATA), V3-V4 16S amplicons from rats - probiotic safety assay (IATA), Shotgun sequencing from human feces - caloric restriction intervention (IATA), V3-V4 - 16S amplicons from mice/probiotic properties 1 (IATA), V3-V4 - 16S amplicons from mice/probiotic properties 2 (IATA), V3-V4 - 16S amplicons from mice/probiotic properties 3 (IATA), V3-V4 - 16S amplicons from mice/probiotic properties 4 (IATA) |